Literature DB >> 3414655

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.

C L Carter1, D K Corle, M S Micozzi, A Schatzkin, P R Taylor.   

Abstract

The authors studied the relation between benign breast disease and subsequent breast cancer in 16,692 women with biopsy-diagnosed benign breast disease who had participated in the Breast Cancer Detection Demonstration Project throughout the United States. Women were classified into one of five benign breast disease categories: atypical hyperplasia, proliferative disease without atypia, nonproliferative disease, fibroadenoma, and other benign breast disease. A total of 485 incident cases of breast cancer were identified in the women from August 1973 to February 1986 after a median follow-up period of 8.3 years from the diagnosis of benign breast disease. Age-adjusted incidence rates were calculated for benign breast disease types stratified by family history and calcification status. Relative risk (RR) estimates of breast cancer for women in the five benign breast disease categories, compared with the screened women who did not develop recognizable breast disease (normal subjects), were computed using the proportional hazards model. Results indicated that risk was associated with the degree of epithelial atypia. Over all age groups, women with nonproliferative disease, proliferative disease without atypia, and atypical hyperplasia displayed progressively increasing risks of 1.5, 1.9, and 3.0, respectively, compared with normal subjects, with 95% confidence intervals (CI) exceeding unity. Particularly high risk was seen among women under age 46 years with atypical hyperplasia (RR = 5.7, 95% CI 3.0-10.6). Women with fibroadenoma as the only indication of their benign breast disease had a relative risk of 1.7, with a lower 95% confidence limit of 1.0. No increased risk was seen for women with other benign breast disease. Positive family history (RR = 1.8) and calcification (RR = 1.2) significantly increased a woman's risk proportionately over the risk associated with each benign breast disease subtype. The authors conclude that the risk of developing breast cancer varies by category of benign breast disease and is directly related to the degree of epithelial atypia.

Entities:  

Mesh:

Year:  1988        PMID: 3414655     DOI: 10.1093/oxfordjournals.aje.a114995

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  66 in total

Review 1.  Clinical and epidemiological issues in mammographic density.

Authors:  Valentina Assi; Jane Warwick; Jack Cuzick; Stephen W Duffy
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  Epithelial Proliferative Lesions and Carcinomas in Fibroadenomas of the Breast.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

3.  Atypical hyperplasia and breast cancer risk: a critique.

Authors:  L Ma; N F Boyd
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

4.  Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.

Authors:  R Moro; J Gulyaeva-Tcherkassova; P Stieber
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

5.  Cerumen phenotype and proliferative epithelium in breast fluids of U.S.-born vs. immigrant Asian women: a possible genetic-environmental interaction.

Authors:  N L Petrakis; E B King; M Lee; R Miike
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

6.  Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.

Authors:  Rulla M Tamimi; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

7.  Risk factors for breast cancer in a black population--the Barbados National Cancer Study.

Authors:  Barbara Nemesure; Suh-Yuh Wu; Ian R Hambleton; M Cristina Leske; Anselm J Hennis
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

8.  A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Authors:  Geoffrey C Kabat; Joan G Jones; Neal Olson; Abdissa Negassa; Catherine Duggan; Mindy Ginsberg; Rita A Kandel; Andrew G Glass; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

9.  Assessment of the accuracy of the Gail model in women with atypical hyperplasia.

Authors:  V Shane Pankratz; Lynn C Hartmann; Amy C Degnim; Robert A Vierkant; Karthik Ghosh; Celine M Vachon; Marlene H Frost; Shaun D Maloney; Carol Reynolds; Judy C Boughey
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

10.  The Er/Ki-67 Proportion in Breast Tumours - An Immunohistochemical Study.

Authors:  M K Rai
Journal:  J Clin Diagn Res       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.